Epidemiology of pancreatic cancer: New version, new vision
- PMID: 37969957
- PMCID: PMC10643340
- DOI: 10.21147/j.issn.1000-9604.2023.05.03
Epidemiology of pancreatic cancer: New version, new vision
Abstract
Pancreatic cancer (PC) is a devastating malignancy with an extremely high mortality rate and poses significant challenges to healthcare systems worldwide. The prevalence of PC risk factors spiked over the years, leading to a global increase in PC incidence rates. The contribution of different risk factors, however, varied from region to region due to genetic predisposition, environmental, social, and political factors underlying disease prevalence in addition to public health strategies. This comprehensive review aims to provide a thorough analysis of the epidemiology of PC, discussing its incidence, risk factors, screening strategies and socioeconomic burden. We compiled a wide range of seminal studies as well as epidemiological investigations to serve this review as a comprehensive guide for researchers, healthcare professionals, and policymakers keen for a more profound understanding of PC epidemiology. This review highlights the essentiality of persistent research efforts, interdisciplinary collaboration, and public health initiatives to address the expanding burden of this malignancy.
Keywords: Pancreatic cancer; epidemiology; future direction; novel data; risk factors.
Copyright ©2023 Chinese Journal of Cancer Research. All rights reserved.
Figures
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Global trends in the incidence and mortality of pancreatic cancer based on geographic location, socioeconomic status, and demographic shift.J Surg Oncol. 2023 Nov;128(6):989-1002. doi: 10.1002/jso.27462. J Surg Oncol. 2023. PMID: 37818913
-
High risk factors of pancreatic carcinoma.J Huazhong Univ Sci Technolog Med Sci. 2016 Jun;36(3):295-304. doi: 10.1007/s11596-016-1583-x. Epub 2016 Jul 5. J Huazhong Univ Sci Technolog Med Sci. 2016. PMID: 27376795 Review.
-
Global, Regional, and National Burden of Pancreatic Cancer, 1990-2019: Results from the Global Burden of Disease Study 2019.Ann Glob Health. 2023 May 25;89(1):33. doi: 10.5334/aogh.4019. eCollection 2023. Ann Glob Health. 2023. PMID: 37252335 Free PMC article.
-
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):493-502. doi: 10.1038/s41575-021-00457-x. Epub 2021 May 17. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34002083 Free PMC article. Review.
Cited by
-
Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer.Pancreatology. 2024 Sep;24(6):878-886. doi: 10.1016/j.pan.2024.07.005. Epub 2024 Jul 15. Pancreatology. 2024. PMID: 39095296 Review.
-
Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer.Chin J Cancer Res. 2025 Jun 30;37(3):466-486. doi: 10.21147/j.issn.1000-9604.2025.03.13. Chin J Cancer Res. 2025. PMID: 40642496 Free PMC article.
-
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements.Drug Deliv. 2024 Dec;31(1):2390022. doi: 10.1080/10717544.2024.2390022. Epub 2024 Aug 13. Drug Deliv. 2024. PMID: 39138394 Free PMC article. Review.
-
Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research.Front Pharmacol. 2025 May 23;16:1543112. doi: 10.3389/fphar.2025.1543112. eCollection 2025. Front Pharmacol. 2025. PMID: 40487412 Free PMC article. Review.
-
Advances and current concepts on Eph receptors and ephrins in upper digestive tract cancers.Front Oncol. 2025 Jan 7;14:1520306. doi: 10.3389/fonc.2024.1520306. eCollection 2024. Front Oncol. 2025. PMID: 39839790 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources